Coulie Bernard sold PLRX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001746473-26-000009

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 20, 2026

Published

Jan 22, 2026

Ingested by INSIDER

Nov 5, 04:21 UTC

Last re-read

Nov 5, 04:21 UTC

Extracted facts

Filer

Coulie Bernard

Role

Director, President and CEO

Transaction

Open-market saleAs filed: “S”

Asset

PLIANT THERAPEUTICS, INC.

Ticker

PLRX

Shares

89.4K

Price per share

$1.28

Value

$114,400

Execution date (reported)

Jan 20, 2026

Owned after transaction

505.6K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

2

Calculation

What this establishes

Coulie Bernard filed this Form 4 reporting a open-market sale of PLRX on Jan 20, 2026. It became public on Jan 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, President and CEO

Coulie Bernardcik:0001808895

Issuer

PLIANT THERAPEUTICS, INC.cik:0001746473

Revision history · 0

No field has changed since this record was first ingested.